PREOPERATIVE SCREENING FOR BLOOD-BORNE INFECTIONS – ESSENTIAL TOOL FOR PATIENTS AND HEALTHCARE
Main Article Content
Keywords
Preoperative, hepatitis B, hepatitis C, human immunodeficiency virus, screening
Abstract
INTRODUCTION: The aim of this study was to examine the magnitude of viral infections as a global health problem, affecting millions around the world. Universal preoperative blood-born HIV virus, HBV, HCV testing has been identified as a universal precautionary risk mitigation strategy. As a universal measure, safety kits are for the surgical team and post-exposure prophylaxis as further protection is mandatory. For patients prior to the onset of AIDS/liver cirrhosis/ hepatocellular carcinoma, early diagnosis of the disease and its treatment is often helpful. The purpose of this analysis was the measurement of HIV/HCV/HBV seroprevalence for successful control programmes.
PATIENTS AND METHODS: In collaboration with the Department of Pathology of the Indus Medical College Hospital, the research was carried out in the Department of Surgery and ALlied, Indus Medical College Tando Muhammad Khan. This analysis is a prospective study for the period from January 2019 to September 2019. Both patients admitted to elective/emergency surgery in the surgery department or those treated conservatively were included in the report. Visitors to The follow-up were removed.
RESULTS: A total of 305 patients admitted to the surgery department have been screened for HBV, HCB and HIV. Hepatitis C (HCV) was a common infection, followed by HBV, but there were also co-infections. The common age group affected was 21-50 years, with a male: female 3.28:1 ratio.
CONCLUSION: As part of routine pre-operative investigations, screening for HIV, HBV and HCV is mandatory in tertiary care centres in order to determine their prevalence and to prepare better preventive strategies.
References
2. Chung RT, Hepatitis C and B viruses: the new opportunities in HIV infection. Top HIV Med. 2006;14:78-83.
3. Alter MJ, Epidemiology of viral hepatitis and coinfections. J Hepatol. 2006; 44: s6-9.
4. WHO (2016), Fact Sheet Hepatitis B, No. 204, June 2016.
5. WHO (2016), Fact Sheet Hepatitis C, No. 164, July 2016.
6. WHO (2015), Country Fact Sheet, HIV/AIDS in Pakistan, Dec. 2015.
7. WHO (2016), Consolidated Guidelines on the use ofAntiretroviral Drugs for Treating and Preventing HIV infection,Recommondation for a Public Health Approach, 2nd Edition, 2016.
8. Bhattacharya S, Badrinath S, Hamide A, Sujatha S. Seroprevalence of hepatitis C virus in a hospital based general population in South India. Indian J Med Microbiol. 2003; 21:43-5.
9. Okonko IO,Anugeje KC and Adeniji FO. Syphillis and HIV HCV and HBsAg co-infections among sexually active adults. Nature and Science 2012; 10: 66-74.
10. Centre for Disease Control and Prevention (2012), Epidemiology and Prevention of Vaccine, Preventable Diseases, 12th Ed., May 2012.
11. National AIDS Control Organization. Antiretroviral Therapy Guidelines for HIV –infected Adults and Adolescents Including Post- exposure Prophylaxis.
12. Ahmed, R., Bhattacharya, S. Universal screening versus universal precautions for HIV, HBV, HCV in India. Indian J Med Microbiol. 2013;31: pp219-25.
13. Nafees M., Ahmed I, ZU Latif, Haq IU. Pre-operative Screening for HBV and HCV Infections; A Preventive Measure! Where are We Today. Biomedica, 2008;24:108-112.